Producing the Covidien-19 Diagnostic Kit Domestic Companies in Turkey

Covidien domestic production of diagnostic kits turkiyede Enterprises
Covidien domestic production of diagnostic kits turkiyede Enterprises

ANATOLIS DIAGNOSIS AND BIOTECHNOLOGY: Producing in Tuzla, the company detects the corona virus in human respiratory samples with the Bosphore Coronavirus (2019-nCoV) diagnostic kit it has developed. The product of the firm, which has four patent applications, is a medical extracorporeal diagnostic kit based on real-time PCR. The company, which currently sells products in more than 200 products in 50 countries, has 70 ministry-approved R&D centers. "Annual production of 1 million tests the company's products are used in more than 80 hospitals and laboratories in Turkey. The company, which produced more than 200 kits and food tests, also produced the coronavirus detection kit. The new coronavirus kits currently produced are used extensively in combating epidemics in 20 countries, including Britain, Italy and France.


Who is Anatolia Geneworks? Founded as a start-up in 90, biotechnology company Anatolia Tanı AŞ, provides world-class molecular diagnostic products used in more than 2014 hospitals and laboratories in Turkey, and exported to more than 32 countries in Europe, Asia, America and Africa. Anatolia, entering global markets under the brand Anatolia Geneworks shortly after it was established, develops and produces high-tech testing kits and devices with its multi-functional team of experts in fields such as genetics, medicine, molecular biology, bioengineering, biology, mechatronics, computer, electronics and mechanical engineering.

SENTROMER DNA TECHNOLOGIES: Sentromer, one of the companies producing COVID-19 diagnostic kit in a short time, is an ITU ARI Technocity company. Centromere DNA Technologies, has over 10 years specializing in synthetic DNA, enzymes needed for Covidien-19 because it is not in Turkey from abroad by providing the sentroplex produces diagnostic kits. The company, which started to produce kits to meet the needs, receives demand from Canada and different countries in Europe. The company applying for a patent has sufficient capacity in kit production.

In order to increase its effectiveness in the overseas market, Anatolia, which has commissioned the Free Zone production facility in Tuzla, continues its R&D and production activities in XNUMX world-class laboratories. In addition to the activities in the field of molecular diagnostics in Turkey, Anatolia takes place in academic and industrial research globally. Anatolia, being one of the few distinguished producers invited to the studies of the World Health Organization (WHO) to determine the new global test reference standards (WHO Collaborative Study), is the only manufacturer who represented Turkey in the study on Real-Time PCR Kits on BK and JC viruses. Anatolia, invited to the WHO Collaborative Studies in XNUMX and XNUMX, also has Hepatitis B (HBV) and Hepatitis C (HCV) Quantitative Real-Time PCR Kits with the highest sensitivity in the world in its product range.

Anatolia Respiratory Pathogens Panel The diagnostic kit developed by the startup company founded in 2019 works on PCR basis. The company has the capacity to produce 15 thousand test kits in 100 days.

Bosphore Novel Coronavirus (XNUMX-nCoV) Detection Kit is a Real-Time PCR-based in vitro diagnostic medical device, IVD CE marked according to XNUMX/XNUMX/EC Directive. Respiratory Pathogens Panel, stands out among the Real Time PCR diagnostic kits produced by Anatolia Geneworks under the brand “Bosphore”. This panel is strategically important for detecting infections whose symptoms are similar to each other and for correct treatment. It is recommended by health authorities that the possibilities of other respiratory pathogens be evaluated for the patient to be tested with suspicion of novel coronavirus. In the content of Bosphore Respiratory Pathogens Panel Kits that detects XNUMX viruses and bacteria* from a single sample of respiratory samples, Coronavirus XNUMXE, Coronavirus OCXNUMX, Coronavirus NLXNUMX and Coronavirus HKUXNUMX are already included. Thanks to the diagnosis made with multiplex panel kits, the pathogen can be easily determined and the right treatment and medicine can be decided. This method has a great importance to prevent antimicrobial resistance. Turkey has ranked first in the ranking of antibiotic resistance according to Organization for Economic Co-operation and Development (OECD).

GENKORD GENETICD: He developed a test kit that can detect coronavirus specific IgM and IgG antibodies in 15 minutes. The product will be ready in a few weeks. The firm has a patent application.

DS BIO and NANO: The diagnostic kit named Coronex COVID-19 developed by the Ankara-based company works on PCR basis. The company has 2 patent applications.

RTA LABORATORIES: Developing a diagnostic kit with the partnership of A1 Yaşam Bilim A.Ş, the laboratory exports the product to different countries. The company has 4 patent applications.



Be the first to comment

Comments